0001209191-23-053510.txt : 20231024
0001209191-23-053510.hdr.sgml : 20231024
20231024194654
ACCESSION NUMBER: 0001209191-23-053510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231023
FILED AS OF DATE: 20231024
DATE AS OF CHANGE: 20231024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benatti Luca
CENTRAL INDEX KEY: 0001613842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 231343688
BUSINESS ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 450 WEST 15TH STREET, SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 450 WEST 15TH STREET, SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER NAME:
FORMER CONFORMED NAME: Luca Benatti
DATE OF NAME CHANGE: 20140715
FORMER NAME:
FORMER CONFORMED NAME: Luca Benatti c/o Intercept Pharmaceuticals, Inc
DATE OF NAME CHANGE: 20140715
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quince Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 901024039
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cortexyme, Inc.
DATE OF NAME CHANGE: 20160104
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-23
0
0001662774
Quince Therapeutics, Inc.
QNCX
0001613842
Benatti Luca
C/O QUINCE THERAPEUTICS, INC.
601 GATEWAY BLVD, SUITE 1250
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Employee Stock Option (right to buy)
0.99
2023-10-23
4
A
0
54000
0.00
A
2033-10-22
Common Stock
54000
54000
D
The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of October 23, 2023, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer as of each such vesting date.
/s/ Brendan Hannah, Attorney-in-Fact for Luca Benatti
2023-10-24